Newsroom

LATEST PUBLICATIONS

Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx

2022-01-04T04:43:02-08:00December 8th, 2021|

Machine Learning Algorithms Accelerate Throughput of a Flow – Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform

2022-01-30T21:35:17-08:00November 5th, 2021|

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing

2022-09-07T22:31:04-07:00June 24th, 2021|

Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma

2023-01-10T16:48:18-08:00April 28th, 2021|

Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

2021-04-27T17:17:21-07:00April 20th, 2021|

Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib

2025-11-27T07:56:39-08:00November 27th, 2018|

Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan

2021-02-26T19:11:48-08:00November 19th, 2018|

Invivoscribe® Receives Approval in Japan for its LeukoStrat® CDx FLT3 Mutation Assay to Assess Acute Myeloid Leukemia (AML) Patients Eligible for Treatment with Xospata® (gilteritinib fumarate)

2025-11-26T15:29:44-08:00September 27th, 2018|

Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels

2021-02-26T19:12:15-08:00May 9th, 2018|

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

2021-02-26T19:12:23-08:00May 8th, 2018|

AMP

Nov 10-14, 2026
Seattle, WA
Exhibiting
Visit Conference Website

68th Japanse Society of Pediatric Hematology/ Oncology

Nov 12 – 14, 2026
Yokohama, Japan
Attending

Medica

Nov 16-19, 2026
Dusseldorf, Germany
Attending
Visit Conference Website

49th the Molecular Biology Society of Japan

Dec 1 – 4, 2026
Yokohama, Japan
Attending

ASH

Dec 12-15, 2026
New Orleans, LA
Exhibiting
Visit Conference Website

Newsroom

Newsroom

LATEST PUBLICATIONS

Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx

Machine Learning Algorithms Accelerate Throughput of a Flow – Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing

Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma

Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

LATEST PRESS

Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib

Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan

Invivoscribe® Receives Approval in Japan for its LeukoStrat® CDx FLT3 Mutation Assay to Assess Acute Myeloid Leukemia (AML) Patients Eligible for Treatment with Xospata® (gilteritinib fumarate)

Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

CONFERENCES

AMP

68th Japanse Society of Pediatric Hematology/ Oncology

Medica

49th the Molecular Biology Society of Japan

ASH

Global Search

SEARCH BY KEYWORD

Global Search

SEARCH BY KEYWORD

Looking for Product Documents?
Try our New Document Search Feature ⟶

Looking for Product Documents?
Try our New Document Search Feature ⟶